$THC

KERREY J ROBERT sold $341K of THC

KERREY J ROBERT sold 1,969 shares of TENET HEALTHCARE CORP (THC) at $173.12 ($0.34M total) on 2026-05-28.

Original reporting
SEC EDGAR · KERREY J ROBERT
Published May 30, 2026, 12:00 AM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai May 30, 2026, 12:01 AM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$THC
Neutral
medium confidence
Mentioned
$THC
Relevance
7/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$THCNeutralLow
01

Why it matters

This disclosure updates insider ownership records but does not include any new operational, financial, or regulatory information about Tenet.

02

Market read

Traders may monitor for follow-on insider activity, but the filing alone is unlikely to drive a sustained repricing.

03

What to watch

Magnitude is modest relative to typical institutional float; insider sales often cluster around tax/portfolio events rather than earnings outlook.

Relevance 7/10Novelty 6/10Timing: Filed after-hours on 2026-05-29 for a sale dated 2026-05-28

Background

The article is an SEC Form 4 insider transaction disclosure for Tenet Healthcare (THC), reporting an open-market sale by a director.

Company-level read

Ticker impact

$THCNeutralMedium confidence
Context

Tenet Healthcare director KERREY J ROBERT sold 1,969 shares in an open-market transaction reported on SEC Form 4.

Expected impact

Low near-term impact; any reaction is likely muted unless followed by additional insider activity or new fundamentals.

Evidence & confidence

The filing is a routine Form 4 open-market sale with no 10b5-1 plan stated and no accompanying company-specific news.

Market effects

Minimal; single-insider Form 4 sale does not reset sector fundamentals for healthcare providers.

None indicated.

None indicated.

Counterpoint

The sale could be routine diversification or liquidity needs; without a 10b5-1 plan, it still may not imply negative expectations.

Key entities

  • Tenet Healthcare Corp

    Subject of the Form 4 insider transaction disclosure.

  • KERREY J ROBERT

    Director who sold shares; transaction details are reported on SEC Form 4.

Related articles

$HCAMed

Uninsured patients rise sharply, hospitals report, citing Obamacare cuts | Chattanooga Times Free Press

More and more uninsured patients are showing up in hospital emergency rooms and clinics, having lost their coverage under the Affordable Care Act. Executives running some of the biggest hospital systems, including large for-profit chains spanning many states, expressed concern over the unexpectedly sharp rise in uninsured patients and the costs associated with treating them.

$THCMedAI 8/10

Tenet raises 2026 outlook after weathering ACA headwinds

Tenet Healthcare raised 2026 guidance after Q2 headwinds on Affordable Care Act exchanges. The company now expects adjusted EBITDA of $4.8B to $5.0B, up from $4.5B to $4.8B. Q2 net income rose to $826M on $5.6B revenue, though ACA revenue fell $65M as ACA admissions declined.

$THCHighAI 9/10

Tenet Healthcare Tops Q2 Earnings Estimates, Raises 2026 Outlook

Tenet Healthcare (THC) reported Q2 2026 adjusted EPS of $6.12, 50% above the Zacks Consensus, with net operating revenues up 6.8% to $5.63B. Adjusted net income rose 39.3% to $514M. The company raised 2026 guidance for revenue, adjusted EBITDA, and adjusted EPS, and authorized a $2B share repurchase increase.

$THCMedAI 8/10

Why Tenet Healthcare Stock Is Soaring Today

Tenet Healthcare (THC) shares rose after the company reported fiscal Q2 results and raised 2026 guidance. For the quarter ended in June, revenue was $5.63B and adjusted EPS was $6.12, both above year-ago figures and analyst estimates ($5.43B revenue, $4.26 EPS). 2026 revenue guidance increased to $21.9B-$22.5B and adjusted EBITDA to $4.83B-$5.03B.